- Home
- BLRX vs RGS Comparison
BLRX vs RGS Comparison
Compare BLRX & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- RGS
- Stock Information
- Founded
- BLRX 2003
- RGS 1922
- Country
- BLRX Israel
- RGS United States
- Employees
- BLRX N/A
- RGS N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- RGS Other Consumer Services
- Sector
- BLRX Health Care
- RGS Consumer Discretionary
- Exchange
- BLRX Nasdaq
- RGS Nasdaq
- Market Cap
- BLRX 17.2M
- RGS 70.8M
- IPO Year
- BLRX 2011
- RGS 1991
- Fundamental
- Price
- BLRX $3.73
- RGS $28.45
- Analyst Decision
- BLRX Strong Buy
- RGS
- Analyst Count
- BLRX 2
- RGS 0
- Target Price
- BLRX $19.00
- RGS N/A
- AVG Volume (30 Days)
- BLRX 34.3K
- RGS 23.9K
- Earning Date
- BLRX 08-14-2025
- RGS 11-05-2025
- Dividend Yield
- BLRX N/A
- RGS N/A
- EPS Growth
- BLRX N/A
- RGS 20.23
- EPS
- BLRX N/A
- RGS 46.10
- Revenue
- BLRX $17,251,000.00
- RGS $210,134,000.00
- Revenue This Year
- BLRX N/A
- RGS N/A
- Revenue Next Year
- BLRX N/A
- RGS N/A
- P/E Ratio
- BLRX N/A
- RGS $0.68
- Revenue Growth
- BLRX 1.19
- RGS 3.52
- 52 Week Low
- BLRX $2.30
- RGS $15.00
- 52 Week High
- BLRX $26.80
- RGS $30.29
- Technical
- Relative Strength Index (RSI)
- BLRX 50.85
- RGS 70.52
- Support Level
- BLRX N/A
- RGS $22.00
- Resistance Level
- BLRX $4.11
- RGS $30.29
- Average True Range (ATR)
- BLRX 0.23
- RGS 1.54
- MACD
- BLRX -0.10
- RGS 0.67
- Stochastic Oscillator
- BLRX 85.55
- RGS 80.89
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.